Gynecologic cancer ovarian cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Breast

Organisms2

Mice, Nude Mice, SCID

Diseases63

Genital Neoplasms, Female Vulvar Neoplasms Ovarian Neoplasms Endometrial Neoplasms Neoplasms, Glandular and Epithelial Uterine Cervical Neoplasms Peritoneal Neoplasms Breast Neoplasms Cystadenocarcinoma, Serous Neoplasms Pancreatic Neoplasms Carcinoma Neoplasm Invasiveness Lung Neoplasms Genital Diseases, Female Prostatic Neoplasms Neoplasm Metastasis Adenocarcinoma, Mucinous Colonic Neoplasms Stomach Neoplasms Adenocarcinoma, Clear Cell Neoplasm Recurrence, Local Fallopian Tube Neoplasms Carcinoma, Endometrioid Genetic Predisposition to Disease Neoplasms, Cystic, Mucinous, and Serous Uterine Neoplasms Disease Progression Carcinoma, Squamous Cell Cystadenocarcinoma Colorectal Neoplasms Adenocarcinoma Neoplasms, Multiple Primary Urinary Bladder Neoplasms Skin Neoplasms Neoplasms, Second Primary Vaginal Neoplasms Liver Neoplasms Cell Transformation, Neoplastic Ascites Carcinoma, Non-Small-Cell Lung Rectal Neoplasms Thyroid Neoplasms Kidney Neoplasms Neoplasms, Radiation-Induced Gastrointestinal Neoplasms Neovascularization, Pathologic Cystadenocarcinoma, Mucinous Bone Neoplasms Mouth Neoplasms Esophageal Neoplasms Adenocarcinoma, Papillary Neoplasms, Experimental Neoplastic Syndromes, Hereditary Head and Neck Neoplasms Cystadenoma, Serous Pelvic Neoplasms Testicular Neoplasms Precancerous Conditions Carcinoma, Pancreatic Ductal Adenoma Carcinoma, Papillary Cystadenoma

Chemicals and Drugs35

CA-125 Antigen Paclitaxel Carboplatin Antineoplastic Agents Tumor Markers, Biological Cisplatin Neoplasm Proteins DNA, Neoplasm Cancer Vaccines BRCA2 Protein Antigens, Neoplasm Antineoplastic Agents, Phytogenic BRCA1 Protein RNA, Messenger Tumor Suppressor Protein p53 RNA, Small Interfering Receptor, erbB-2 Receptors, Estrogen Antibodies, Monoclonal Platinum Compounds RNA, Neoplasm Antineoplastic Agents, Hormonal Epididymal Secretory Proteins Receptors, Progesterone Topotecan Prostate-Specific Antigen Taxoids Tamoxifen Tumor Suppressor Proteins Antibodies, Monoclonal, Humanized Fluorouracil MicroRNAs Receptor, Epidermal Growth Factor Transcription Factors DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Gynecologic Surgical Procedures Salpingostomy Hysterectomy Early Detection of Cancer Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Questionnaires Risk Factors Prospective Studies Follow-Up Studies Neoplasm Staging Treatment Outcome Incidence Prognosis Survival Analysis Survival Rate Disease-Free Survival Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Risk Gene Expression Profiling Cross-Sectional Studies Immunohistochemistry Combined Modality Therapy Neoplasm Transplantation Sensitivity and Specificity Risk Assessment Registries Blotting, Western Odds Ratio Kaplan-Meier Estimate Neoplasm Grading Oligonucleotide Array Sequence Analysis Chemotherapy, Adjuvant Drug Administration Schedule Transplantation, Heterologous Multivariate Analysis Polymerase Chain Reaction Predictive Value of Tests SEER Program Drug Screening Assays, Antitumor Reproducibility of Results Tissue Array Analysis Genetic Testing Clinical Trials as Topic Logistic Models Immunoenzyme Techniques Neoplasms, Experimental Laparoscopy Tumor Burden Transfection Obstetric Surgical Procedures Molecular Targeted Therapy DNA Mutational Analysis Cohort Studies Ovariectomy Flow Cytometry Confidence Intervals Mammography Biopsy Gene Knockdown Techniques Pelvic Exenteration

Psychiatry and Psychology3

Adaptation, Psychological Depression Smoking

Phenomena and Processes34

Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genes, BRCA2 Genetic Predisposition to Disease Mutation Risk Germ-Line Mutation Sensitivity and Specificity Cell Proliferation Odds Ratio DNA Methylation Apoptosis Cell Survival Dose-Response Relationship, Drug Cell Movement Genotype Cell Division Down-Regulation Genes, Tumor Suppressor Cell Growth Processes Cell Cycle Signal Transduction Up-Regulation Polymorphism, Genetic Transfection Promoter Regions, Genetic RNA Interference Gene Silencing Genes, Neoplasm Genes, p53 Time Factors Gene Expression Base Sequence

Disciplines and Occupations3

Gynecology Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Socioeconomic Factors National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science6

Questionnaires Incidence Survival Rate Registries SEER Program Base Sequence

Named Groups1

Health Care29

Retrospective Studies Questionnaires Risk Factors Prospective Studies Follow-Up Studies Treatment Outcome Incidence Survival Analysis Survival Rate Disease-Free Survival Risk Cross-Sectional Studies Sensitivity and Specificity Risk Assessment Registries Age Factors Socioeconomic Factors Odds Ratio Kaplan-Meier Estimate National Cancer Institute (U.S.)Multivariate Analysis Predictive Value of Tests SEER Program Reproducibility of Results Genetic Testing Clinical Trials as Topic Logistic Models Cohort Studies Confidence Intervals

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Genital Neoplasms, Female Vulvar Neoplasms Ovarian Neoplasms Endometrial Neoplasms Gynecologic Surgical Procedures Salpingostomy CA-125 Antigen Gynecology Neoplasms, Glandular and Epithelial Uterine Cervical Neoplasms Hysterectomy Peritoneal Neoplasms Breast Neoplasms Survivors Paclitaxel Carboplatin Antineoplastic Agents Early Detection of Cancer Quality of Life Cystadenocarcinoma, Serous Neoplasms Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Pancreatic Neoplasms Carcinoma Questionnaires Risk Factors Neoplasm Invasiveness Prospective Studies Gene Expression Regulation, Neoplastic Follow-Up Studies Cell Line, Tumor Neoplasm Staging Treatment Outcome Genes, BRCA1 Tumor Markers, Biological Lung Neoplasms Genital Diseases, Female United States Incidence Prostatic Neoplasms Prognosis Neoplasm Metastasis Cisplatin Drug Resistance, Neoplasm Neoplasm Proteins Mice, Nude Adenocarcinoma, Mucinous Colonic Neoplasms Stomach Neoplasms Adenocarcinoma, Clear Cell Survival Analysis Neoplasm Recurrence, Local Adaptation, Psychological Fallopian Tube Neoplasms Carcinoma, Endometrioid Survival Rate Genes, BRCA2 Genetic Predisposition to Disease Disease-Free Survival DNA, Neoplasm Neoplasms, Cystic, Mucinous, and Serous Uterine Neoplasms Disease Progression Depression Reverse Transcriptase Polymerase Chain Reaction Mutation Xenograft Model Antitumor Assays Risk Gene Expression Profiling Cross-Sectional Studies Cancer Vaccines Immunohistochemistry BRCA2 Protein Antigens, Neoplasm Carcinoma, Squamous Cell Antineoplastic Agents, Phytogenic Cystadenocarcinoma Colorectal Neoplasms Medical Oncology Combined Modality Therapy Adenocarcinoma BRCA1 Protein RNA, Messenger Neoplasm Transplantation Neoplasms, Multiple Primary Urinary Bladder Neoplasms Germ-Line Mutation Sensitivity and Specificity Skin Neoplasms Cell Proliferation Neoplasms, Second Primary Risk Assessment Registries Age Factors Socioeconomic Factors Tumor Cells, Cultured Blotting, Western Tumor Suppressor Protein p53 Odds Ratio

No FAQ available that match "gynecologic cancer ovarian cancer vulvar neoplasms"